{| class="infobox" style="border-spacing:2px;"
|+ class="infobox-title" id="5" |Tetrahidrokanabiol<br /><br /><span style="font-size:85%; font-weight:normal;"><abbr title="International nonproprietary name">INN</abbr>:</span> dronabinol
| colspan="2" class="infobox-image" |[[File:THC.svg|frameless]]
|-
| colspan="2" class="infobox-image" |[[File:Delta-9-tetrahydrocannabinol-from-tosylate-xtal-3D-balls.png|frameless]]
|-
! colspan="2" class="infobox-header" style="background:#ddd" |Të dhënat klinike
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |[[Drug nomenclature#Trade names|Emrat e tregtimit]]
| class="infobox-data" |Marinol, Syndros
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Emrat e tjerë
| class="infobox-data" |(6a''R'',10a''R'')-delta-9-Tetrahidrokanabinol; (−)-''trans''-Δ<sup>9</sup>-Tetrahidrokanabinol; THC
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |[[Regulation of therapeutic goods|Të dhënat e licensimit]]
| class="infobox-data" |<templatestyles src="Plainlist/styles.css" /><div class="plainlist ">
* <small><abbr class="country-name" title="<nowiki&gt;United States</nowiki&gt;">US</abbr></small>&nbsp;<span title="www.accessdata.fda.gov">FDA:&nbsp;[https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Dronabinol&SearchType=BasicSearch Dronabinol]</span>
</div>
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |[[Varësia nga substancat (droga)|Përgjegjësia e varësisë]]
| class="infobox-data" |E ulët -e moderuar 8–10%
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Përgjegjësia e varësisë 
| class="infobox-data" |Relatively low: 9%
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Rrugët e administrimit
| class="infobox-data" |Goja, vendore/topikale, ndërlëkurë, nëngjuhë, e thithur
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Klasa e drogës
| class="infobox-data" |Kanabinoid
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Kodi ATC
| class="infobox-data" |<templatestyles src="Plainlist/styles.css"></templatestyles><div class="plainlist">
* A04AD10&#x20;(<span title="www.whocc.no">[https://www.whocc.no/atc_ddd_index/?code=A04AD10 WHO]</span>)&#x20;
</div>
|-
! colspan="2" class="infobox-header" style="background:#ddd" |Të dhënat farmakokinetike
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Biogatishmëria
| class="infobox-data" |10–35% (thithëse), 6–20% (gojore)
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Shusa e proteinave
| class="infobox-data" |97–99%<ref name="pmid12648025" />
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Metabolizmi
| class="infobox-data" |Më së shumti hepatik nga CYP2C<ref name="pmid12648025" />
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Periudha e gjysëm-eleminimit
| class="infobox-data" |1.6–59 h,<ref name="pmid12648025" /> 25–36 h (i administruar nëpërmjet gojës)
|-
! class="infobox-label" scope="row" style="line-height:1.2em;" |Ekskretimi
| class="infobox-data" |65–80% (feçe), 20–35% (urinë) <ref name="pmid12648025" />
|-
! colspan="2" class="infobox-header" style="background:#ddd" |Identifikuesit
|-
| colspan="2" class="infobox-full-data" |<div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;">
<div style="line-height: 1.6em; font-weight: bold;"><div>Emri IUPAC</div></div>